CLASS I Drug recall · Reported 14 May 2025 · FDA Enforcement Report

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per (5mg/mL) recalled

Amneal Pharmaceuticals is recalling Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per (5mg/mL), distributed nationwide in the US. The recall was initiated on 17 Apr 2025 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #'s: AL240003, AL240004, Exp.: 01/31/2026
NDC70121-1732, 70121-1733, 70121-1734, 70121-1735
UPC0370121173533, 0370121173434, 0370121173335, 0370121173311, 0370121173410, 0370121173519
Quantity recalled62 (12x100mL) bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0402-2025
FDA event ID
96648
Recalling firm
Amneal Pharmaceuticals, Bridgewater, NJ
Manufacturer
Amneal Pharmaceuticals LLC
Classification
Class I
Status
Completed
Recall initiated
17 Apr 2025
FDA classified
5 May 2025
Reported
14 May 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

17 Apr 2025Recall initiated by company
5 May 2025Classified by FDA+18 days
14 May 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter

Product as listed by the FDA

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

Where it was distributed

Nationwide in the US

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter

Which lots are affected?

Lot #'s: AL240003, AL240004, Exp.: 01/31/2026

Where was it sold?

Nationwide in the US

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 9 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amneal Pharmaceuticals

All 25

Other Ropivacaine recalls

All 14